post
410
oligosaccharide
spectroscopy
roldan
carbohydrate
aimed
124
present
antidiabetic
cell
open
dark
2019
hydrogen
malik
measured
role
than
had
herbal
showed
potency
042
extract_250_mg
maximum
victor
kesehatan
chemical
pharmacy
study
aging
ilmu
concept
vivo
teresa
discussion
kinetic
DPPH
microvascular
USA
khairun
calculation
keyword
leave
streptozotocin
disease
aim
error
hidalgo
cancer
425
caused
354
hartati
technology
occur
sekolah
decrease
cleavage
muthulingam
basic
bound
dose
interaction
interdisciplinary
react
without
result
spectrochimica
27x
crispu
induced
481
picrylhydrazyl
sri
uncompetitive
explain
sharealike
taking
line
hamidu
inhibition
example
both
health
adequately
dropping
absorbance
who
data
chiu
fresh
388
different
new
slightly
add
undefined
activity
cause
delfani
part
continue
element
derived
free
conclusion
animal
regression
correlation
termed
elsevier
eating
taxonomic
submission
buthanol
sig
acetate
antioxidant
value
IV
nutritiou
treatment
valid
out
917
nedunchezhian
review
enterocyte
nesco
mohammed
radix
celebe
hsu
fitofarmakaindo
155
oxidation
comparative
III
play
increase
upper
common
9978
electron
month
test
many
important
abelmoschu
stres
antihyperlipidemic
minute
pascual
invivo
2007
author
triplicate
formula
alpha
fractioned
standard
200
african
will
vitro
org
516
rocha
there
268
295
sano
two
chromatography
related
aktsar
food
tumor
copyright
1007
fitofarmaka
blood
hara
ramados
wic
yap
global
kanunang
nur
696
postprandial
reduce
normal
DOI
doi
121
lin
blank
fact
radical
2010
plant
old
affected
sola
watanabe
hajinezhad
2017
2011
certain
international
solution
sheet
100230
jm
though
hamidu3
275
phytochemistry
even
consumption
compound
nanoparticle
abad
long
pharmtech
403
sulawesi
laboratory
comparing
determined
myxa
metabolic
288
when
201
following
disaccharide
testing
vi
edible
severity
purple
indonesia
activitie
875
ingredient
mixed
donate
chemoprofiling
inhibiting
obliqua
farmasi
miri
term
abstract
pharmacist
functional
positive
absorption
table
mora
subsequent
alumina
rat
anti
deep
thermo
show
difference
experiment
young
brand
266
spectroscopic
umi
yousef
performance
inhibitor
biomolecular
indicated
345
attribution
temperature
243
php
inflammation
sugar
wavelength
strip
still
type
jover
min
nisaa1
silica
division
moreno
namely
031
studie
while
33096
analysi
analytical
significant
individual
standardized
diabetic
wari
confidence
oriental
analyzed
std
hexane
10S
rezky
inermi
concentration
extract
DFT
2016
structure
enzyme
salom
emergence
IC50
3923
advancement
previou
between
medical
stable
032
latest
change
assay
004
204
417
prevented
drug
tinggi
nisaa
gummy
least
3390
yellow
atta
effect
spectrophotometer
0271
license
9987
unstable
taufiq
science
light
issue
najib
acoru
natural
168
determination
anisa
sanchez
lowering
because
lawsonia
elya
product
proton
partial
brief
computational
it
into
studied
modified
before
wijesekara
male
scavenging
botanical
intestinal
degenerative
glucose
evaluation
100
bandar
cure
nature
several
scavenge
mechanism
material
burgo
syndrome
1016
strobilanthe
chemistry
info
CMC
ahmad
191
diphenyl
plasma
regency
chinsembu
merck
three
ihibition
prepared
fraction
iannantuoni
R2
aldrich
liu
creative
calculated
pharma
multicheck
GENESYS
used
figure
hoc
cordia
kit
s13596
picryl
classified
journal
hashemi
introduction
949
quercetin
one
ha
vol
chapter
bioassay
UV
highest
also
statistic
acta
manihot
detail
287
look
lampung
jimenez
628
870
square
500
south
rehmanniae
color
projection
negative
calamu
2018
418
purified
organization
foodchem
time
william
jyp
form
hydrazyl
interval
clinical
apparatu
017
latent
0832x
charle
world
divided
active
affect
medik
wiley
abdi
twenty
scientific
mellitu
distributed
enrekang
use
www
empirically
2022
propertie
120
albino
genu
210
ismail
ethyl
lanka
index
strong
1261
lower
ibrahim
ANOVA
1098
kept
int
handayani
pharmacognosy
rahman
statistical
relationship
sample
II
against
691
gel
using
jffi
obtained
model
097
270
jcm8091385
added
diabete
5530
inhibitory
indonesian
najib2
visible
lopez
acces
identification
short
microgram
pathogenesi
517
domenech
someya
metformin
hermed
assayed
inhibit
1002
dib
zamani
854
method
putative
cardiovascular
property
curve
431
reference
halim
500mg
function
hibiscu
128
universita
ELISA
symptom
dewi
molecular
but
regulate
kandi
medication
complication
level
sagane
spectrophotometric
reacted
commonly
nasab
pair
wa
well
inhibited
escribano
ppm
013
experimental
cytotoxicity
alternative
AB
v9i3
chronic
evidenced
followed
ER
conventional
leaf
338
alloxan
invitro
roskiana
pratiwi
moradi
preparation
comparison
system
after
virsa
291
AA
traditional
PLS
determine
done
sigma
battle
accepted
reducing
efficacy
each
184
saa
potential
medicinal
1165
402
barrier
maranon
muslim
326
seen
daily
develop
administered
hydrazil
department
then
flavonoid
under
moron
314
endrini
ranged
376
krishnamoorthy
mean
dsx
control
violet
jff
article
makassar
handayani1
comparator
suppl
mice
818
oxidative
glucosidase
islam
2009
prandial
toward
rahmat
same
ahmad2
299
group
1172
measurement
email
taken
jurnal
103
room
isolate
adila
jabbari
ramakrishnan
their
110
medicine
villi
215
four
history
321
040
methanol
faculty
column
250
carried
bristle
decreasing
research
http